HDAC4 and Parkinson disease: Current results indicated that Class IIa HDACs had a detrimental effect on dopaminergic neurons, and the inhibition or cytoplasmic shuttling of Class IIa HDACs (at least HDAC4 or HDAC5) might improve the neuroprotective effects in PD [51,60].